AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ELEVRA LITHIUM LTD

7.570

+0.1401.88%

Volume:785.22K

Turnover:5.84M

Market Cap:1.28B

PE:-1.85

High:7.650

Open:7.280

Low:7.190

Close:7.430

52wk High:10.330

52wk Low:2.100

Shares:169.33M

Float Shares:94.13M

Volume Ratio:0.70

T/O Rate:0.83%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.095

EPS(LYR):-4.095

ROE:-26.34%

ROA:-8.87%

PB:1.60

PE(LYR):-1.85

Loading ...

Overview Company News Filings

A Look At Elevra Lithium’s Valuation As First-Half FY26 Results Swing To Profit

Simply Wall St.

Elevra Lithium’s Swing to Half‑Year Profit Might Change The Case For Investing In Elevra (ASX:ELV)

Simply Wall St.

Elevra Lithium Limited Publishes Carolina Lithium Town Hall Presentation on Project Updates and Air Permit Review

Elevra Lithium Limited Publishes Investor Presentation on North American Hard-Rock Lithium Supply and Growth Strategy

Why Elevance Health (ELV) Is Up 6.5% After Earnings Beat, Outlook Hike and Bigger Buybacks

Simply Wall St.

Elevra Lithium Signs Non-Binding MoU to Supply Spodumene Concentrate to Mangrove Lithium

BUZZ-Elevra Lithium rises on potential spodumene supply deal

BRIEF-Elevra Lithium Signs Offtake MoU With Mangrove Lithium

Elevra Lithium Limited unterzeichnet Absichtserklärung zur Lieferung von Spodumenkonzentrat an Mangrove Lithium

Elevra Lithium Ltd - Signs Non-Binding Offtake Mou With Mangrove Lithium

THOMSON REUTERS

Elevra Lithium Ltd - to Supply up to 144,000 Tonnes per Year of Spodumene Concentrate to Mangrove

THOMSON REUTERS

ASX Biggest Gainers

MT Newswires Live

Growth Investors: Industry Analysts Just Upgraded Their Elevra Lithium Limited (ASX:ELV) Revenue Forecasts By 12%

Simply Wall St.

Q2 Metals Appoints Keith Phillips as Executive Chair

Assessing Elevance Health (ELV) Valuation After Recent Share Price Weakness

Simply Wall St.

Stardust Power Appoints Bruce Czachor as General Counsel

Is Elevra Lithium (ASX:ELV) Fairly Priced After Recent Share Price Pullback?

Simply Wall St.

Is Elevance Health (ELV) Using Rising Revenue and a Higher Dividend to Redefine Its Capital Strategy?

Simply Wall St.

GUIDANCE: (ELV) Elevance Health Expects 2026 Adjusted EPS At Least $25.50

MT Newswires Live

Elevra Lithium Posts Lower Fiscal Q2 Spodumene Concentrate Production at Canada Project; Shares Fall 10%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ELV.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ELV.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ELV.AU\",,,,,undefined,":{"symbol":"ELV.AU","market":"AU","secType":"STK","nameCN":"ELEVRA LITHIUM LTD","latestPrice":7.57,"timestamp":1773378720000,"preClose":7.43,"halted":0,"volume":785217,"delay":0,"changeRate":0.01884253028263803,"nameEN":"ELEVRA LITHIUM LTD","floatShares":94132708,"shares":169329111,"eps":-4.095095,"marketStatus":"Closed","change":0.14,"latestTime":"03-13 16:12:00 AEDT","open":7.28,"high":7.65,"low":7.19,"amount":5842630,"amplitude":0.061911,"askPrice":7.65,"askSize":3078,"bidPrice":7.45,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":-4.095095,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1773615600000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":7.43,"openAndCloseTimeList":[[1773356400000,1773378000000]],"volumeRatio":0.702941,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ELV.AU","preClose":7.43,"auctionPrice":7.57,"auctionVolume":35152,"auctionTime":1773378599964,"referencePrice":7.57,"referenceTime":1773394203089,"auction":3,"marketStatus":"盘后竞价","timestamp":1773378599964}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ELV.AU\",,,,,undefined,":{"symbol":"ELV.AU","floatShares":94132708,"roa":"-8.87%","roe":"-26.34%","lyrEps":-4.095095,"volumeRatio":0.702941,"shares":169329111,"dividePrice":0,"high":7.65,"amplitude":0.061911,"preClose":7.43,"low":7.19,"week52Low":2.1,"pbRate":"1.60","psRate":"5.82","week52High":10.33,"institutionHeld":0,"latestPrice":7.57,"committee":-0.012833,"eps":-4.095095,"divideRate":0,"volume":785217,"delay":0,"ttmEps":-4.095095,"open":7.28,"prevYearClose":8.04,"prevWeekClose":7.56,"prevMonthClose":8.16,"prevQuarterClose":8.04,"fiveDayClose":7.56,"twentyDayClose":7.38,"sixtyDayClose":6.73,"dividendPayoutRate":0,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ELV.AU\",params:#limit:5,,,undefined,":[{"date":"2026-02-24","symbol":"ELV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771887600000,"name":null,"time":"","dateTimestamp":1771851600000,"actualEps":null},{"date":"2026-01-28","symbol":"ELV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1769554800000,"name":null,"time":"","dateTimestamp":1769518800000,"actualEps":null},{"date":"2025-10-29","symbol":"ELV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761692400000,"name":null,"time":"","dateTimestamp":1761656400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ELV.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ELV.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2614029541","title":"A Look At Elevra Lithium’s Valuation As First-Half FY26 Results Swing To Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2614029541","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614029541?lang=en_us&edition=fundamental","pubTime":"2026-02-26 21:32","pubTimestamp":1772112762,"startTime":"0","endTime":"0","summary":"Elevra Lithium (ASX:ELV) is back in focus after reporting first half FY26 results that moved from a prior loss to a US$74 million profit, alongside higher revenue and steady North American Lithium operations.\nSee our latest analysis for Elevra Lithium.\nAt a latest share price of A$8.20, Elevra Lithium’s momentum has been mixed, with a 7 day share price return of 5.13% and a 90 day share price return of 41.87%. The 1 year total shareholder return of 148.48% contrasts with a 3 year total...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-elv/elevra-lithium-shares/news/a-look-at-elevra-lithiums-valuation-as-first-half-fy26-resul","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-elv/elevra-lithium-shares/news/a-look-at-elevra-lithiums-valuation-as-first-half-fy26-resul","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ELV.AU","BK7095","BK4168","ELVR","DCF"],"gpt_icon":0},{"id":"2614081927","title":"Elevra Lithium’s Swing to Half‑Year Profit Might Change The Case For Investing In Elevra (ASX:ELV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614081927","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614081927?lang=en_us&edition=fundamental","pubTime":"2026-02-25 18:36","pubTimestamp":1772015778,"startTime":"0","endTime":"0","summary":"Elevra Lithium Limited has released half-year results for the period ended December 31, 2025, reporting sales of US$86.23 million and net income of US$72.62 million, compared with sales of US$80.15 million and a net loss of US$34.2 million a year earlier.\nThis move from loss to profit, alongside basic earnings per share from continuing operations rising from a loss of US$0.4992 to earnings of US$0.5358, marks a clear shift in the company’s recent financial profile.\nWe’ll now examine how...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-elv/elevra-lithium-shares/news/elevra-lithiums-swing-to-halfyear-profit-might-change-the-ca","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-elv/elevra-lithium-shares/news/elevra-lithiums-swing-to-halfyear-profit-might-change-the-ca","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0289739699.SGD","LU1201861249.SGD","LU2362541273.HKD","LU0234570918.USD","LU0878866978.SGD","LU0980610538.SGD","LU0058720904.USD","LU1489326972.SGD","SG9999003800.SGD","LU0122379950.USD","LU1983299246.USD","LU1548497426.USD","LU0251131958.USD","LU0640476718.USD","LU1057294990.SGD","LU1280957306.USD","LU0048573561.USD","LU0345770993.USD","BK4588","LU0345770308.USD","LU0068578508.USD","LU0557290698.USD","LU2237957902.USD","LU2362540622.SGD","LU1670628061.USD","SG9999001077.SGD","LU0170899867.USD","LU0882574055.USD","BK4154","LU0251142724.SGD","LU2237957811.SGD","LU1023059063.AUD","LU0130517989.USD","LU2505996509.AUD","LU0114720955.EUR","BK4585","LU0266013472.USD","LU2505996681.GBP","LU2244417387.USD","ELV","LU0208291251.USD","LU2430703178.SGD","ELV.AU","LU1815333072.USD","LU1670627923.USD","SG9999004303.SGD","BK7095","LU0106261372.USD","LU0061474960.USD","LU1720051017.SGD"],"gpt_icon":0},{"id":"2613852761","title":"Elevra Lithium Limited Publishes Carolina Lithium Town Hall Presentation on Project Updates and Air Permit Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2613852761","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613852761?lang=en_us&edition=fundamental","pubTime":"2026-02-24 13:39","pubTimestamp":1771911590,"startTime":"0","endTime":"0","summary":"Elevra Lithium Limited released a Carolina Lithium town hall presentation outlining the project’s status and key development requirements. The company described Carolina Lithium as a fully integrated mine-to-chemical project in North Carolina with potential capacity of up to 60 kt per year of battery-grade lithium, and noted it received a finalized state mining permit in May 2024, along with general stormwater permits. Elevra said its air permit application remains under review by the North Carolina Department of Environmental Quality’s Division of Air Quality, with next steps including a draft permit for public comment, a state-led public hearing, and a final permit decision. The presentation also stated construction would begin only after all approvals are complete, including county rezoning, securing financing, and establishing operators for the chemical processing portion of the project. You can access the full presentation through the link below.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL1DQ2pJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7095","ELV.AU"],"gpt_icon":0},{"id":"2612219424","title":"Elevra Lithium Limited Publishes Investor Presentation on North American Hard-Rock Lithium Supply and Growth Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2612219424","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612219424?lang=en_us&edition=fundamental","pubTime":"2026-02-19 05:30","pubTimestamp":1771450230,"startTime":"0","endTime":"0","summary":"Elevra Lithium Limited released a conference presentation outlining its operating portfolio and development plans as a North American hard-rock lithium producer listed on ASX  and Nasdaq . The presentation highlights a combined attributable ore reserve estimate of 106Mt at 1.15% LiO and an attributable measured and indicated mineral resource estimate of 183Mt at 1.16% LiO, and provides updates across its assets including North American Lithium , Moblan (60%), Carolina Lithium , Authier, and Ewoyaa . The company also summarizes recent North American Lithium operating metrics for Q2 FY26, including 44,154 dry metric tonnes produced, 66,016 dry metric tonnes sold, 62% recovery, revenue of US$66 million, and unit operating cost  of US$812. The presentation discusses a staged brownfield expansion plan at North American Lithium targeting increased concentrate production capacity to 315 ktpa and includes an overview of a non-binding supply MOU with Mangrove Lithium for up to 144,000 tonnes pe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nNDL6lltB9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELV.AU","BK7095"],"gpt_icon":0},{"id":"2612495906","title":"Why Elevance Health (ELV) Is Up 6.5% After Earnings Beat, Outlook Hike and Bigger Buybacks","url":"https://stock-news.laohu8.com/highlight/detail?id=2612495906","media":"Simply Wall St.","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612495906?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:24","pubTimestamp":1771363483,"startTime":"0","endTime":"0","summary":"Elevance Health recently reported another earnings beat, raised its outlook, and authorized billions of dollars in additional share buybacks, underscoring tight control over utilization and pricing.\nDespite its scale, capital returns, and reputation as a defensive growth name, the company still appears underappreciated by many US investors.\nWith Elevance Health boosting its outlook and accelerating buybacks, we'll explore how this earnings momentum affects the existing investment...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/why-elevance-health-elv-is-up-65-after-earnings-beat-outlook","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/why-elevance-health-elv-is-up-65-after-earnings-beat-outlook","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ELV","ELV.AU"],"gpt_icon":0},{"id":"2610958510","title":"Elevra Lithium Signs Non-Binding MoU to Supply Spodumene Concentrate to Mangrove Lithium","url":"https://stock-news.laohu8.com/highlight/detail?id=2610958510","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610958510?lang=en_us&edition=fundamental","pubTime":"2026-02-11 21:31","pubTimestamp":1770816686,"startTime":"0","endTime":"0","summary":"Elevra Lithium Limited has announced the signing of a non-binding Memorandum of Understanding  with Mangrove Lithium for the potential supply of spodumene concentrate produced at North American Lithium . The MoU outlines intentions to negotiate a definitive agreement under which Elevra could supply up to 144,000 tonnes per year of spodumene concentrate to Mangrove at market-related prices, subject to a floor and ceiling price. The proposed supply would cover an initial five-year period starting in 2028 and ramp up to the full volume by 2030, representing approximately 46% of Elevra's estimated sales volumes. A binding agreement is subject to Mangrove making a final investment decision before June 2027 on the construction of a lithium conversion facility and the parties reaching agreement on final terms.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nNDL5vZHdx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7095","ELV.AU"],"gpt_icon":0},{"id":"2610950676","title":"BUZZ-Elevra Lithium rises on potential spodumene supply deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2610950676","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610950676?lang=en_us&edition=fundamental","pubTime":"2026-02-10 10:07","pubTimestamp":1770689242,"startTime":"0","endTime":"0","summary":"BUZZ-Elevra Lithium rises on potential spodumene supply deal** North American lithium producer Elevra Lithium ELV.AX shares rise 6.3% to A$7.64, their highest level since January 29** Elevra signs non-binding MoU to supply Mangrove Lithium with spodumene concentrate ** Parties intend to negotiate definitive agreement under which co could supply up to 144,000 tonnes per year of spodumene concentrate to Mangrove at market-related prices, subject to floor and ceiling prices** Stock down 4.9% YTD, after falling 10.6% in 2025","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nL6N3Z605Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELV.AU","BK7095"],"gpt_icon":0},{"id":"2610693443","title":"BRIEF-Elevra Lithium Signs Offtake MoU With Mangrove Lithium","url":"https://stock-news.laohu8.com/highlight/detail?id=2610693443","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610693443?lang=en_us&edition=fundamental","pubTime":"2026-02-10 09:31","pubTimestamp":1770687104,"startTime":"0","endTime":"0","summary":"BRIEF-Elevra Lithium Signs Offtake MoU With Mangrove LithiumFeb 10  - Elevra Lithium Ltd ELV.AX:SIGNS NON-BINDING OFFTAKE MOU WITH MANGROVE LITHIUMTO SUPPLY UP TO 144,000 TONNES PER YEAR OF SPODUMENE CONCENTRATE TO MANGROVEFurther company coverage: ELV.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nFWN3Z51MP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELV.AU","BK7095"],"gpt_icon":0},{"id":"2610166427","title":"Elevra Lithium Limited unterzeichnet Absichtserklärung zur Lieferung von Spodumenkonzentrat an Mangrove Lithium","url":"https://stock-news.laohu8.com/highlight/detail?id=2610166427","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610166427?lang=en_us&edition=fundamental","pubTime":"2026-02-10 06:58","pubTimestamp":1770677882,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elevra Lithium Limited published the original content used to generate this news brief via GlobeNewswire  on February 09, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL5c6FlL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","SG9999014005.SGD","IE00BKPKM429.USD","LU2210149790.SGD","LU2095319765.USD","IE00B3QW5Z07.USD","SG9999014039.USD","ELV.AU","BK4585","NDAQ","SG9999014013.SGD","LU0314104364.USD","BK7095","SG9999014021.USD","BK4112","BK4588","IE00B64PRP62.GBP","LU2210150020.SGD"],"gpt_icon":0},{"id":"2610666602","title":"Elevra Lithium Ltd - Signs Non-Binding Offtake Mou With Mangrove Lithium","url":"https://stock-news.laohu8.com/highlight/detail?id=2610666602","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610666602?lang=en_us&edition=fundamental","pubTime":"2026-02-10 05:16","pubTimestamp":1770671802,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nFWN3Z51MP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","ELV.AU"],"gpt_icon":0},{"id":"2610066699","title":"Elevra Lithium Ltd - to Supply up to 144,000 Tonnes per Year of Spodumene Concentrate to Mangrove","url":"https://stock-news.laohu8.com/highlight/detail?id=2610066699","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610066699?lang=en_us&edition=fundamental","pubTime":"2026-02-10 05:16","pubTimestamp":1770671802,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nFWN3Z51MP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELV.AU","BK7095"],"gpt_icon":0},{"id":"2610500629","title":"ASX Biggest Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2610500629","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610500629?lang=en_us&edition=fundamental","pubTime":"2026-02-09 11:51","pubTimestamp":1770609078,"startTime":"0","endTime":"0","summary":"Here are the 10 ASX-listed companies with the biggest gains on Monday.Bravura Solutions : +28%, AU$2.31Web Travel Group : +18%, AU$3.48Weebit Nano : +15%, AU$4.98Elevra Lithium : +13%, AU$7.27Dateline Resources : +12%, AU$0.32Almonty Industries : +12%, AU$19.84Orezone Gold : +11%, AU$2.61Resolute Mining : +10%, AU$1.39Robex Resources : +10%, AU$6.46Silex Systems : +10%, AU$6.69","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ORE.AU","BK7503","AII.AU","BK7098","BK7070","BK7506","BK7088","DTR.AU","BK7095","ELV.AU","WEB.AU","BK7069","BK7016","WBT.AU","SLX.AU","RXR.AU","RSG.AU","BK7104","BVS.AU"],"gpt_icon":0},{"id":"2609352420","title":"Growth Investors: Industry Analysts Just Upgraded Their Elevra Lithium Limited (ASX:ELV) Revenue Forecasts By 12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609352420","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609352420?lang=en_us&edition=fundamental","pubTime":"2026-02-08 06:58","pubTimestamp":1770505126,"startTime":"0","endTime":"0","summary":"Elevra Lithium Limited ( ASX:ELV ) shareholders will have a reason to smile today, with the analysts making substantial...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-elv/elevra-lithium-shares/news/growth-investors-industry-analysts-just-upgraded-their-elevr","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-elv/elevra-lithium-shares/news/growth-investors-industry-analysts-just-upgraded-their-elevr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ELV","ISBC","ELV.AU"],"gpt_icon":0},{"id":"2608873908","title":"Q2 Metals Appoints Keith Phillips as Executive Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2608873908","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608873908?lang=en_us&edition=fundamental","pubTime":"2026-02-03 20:00","pubTimestamp":1770120028,"startTime":"0","endTime":"0","summary":"Q2 Metals Corp. has appointed Keith Phillips as Executive Chair of its Board of Directors, effective immediately. Phillips joined the board in October 2025 after previously serving as CEO of Piedmont Lithium.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Q2 Metals Corp. published the original content used to generate this news brief via GlobeNewswire  on February 03, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nNDLbkzks6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4588","NDAQ","SG9999014005.SGD","LU2095319765.USD","SG9999014039.USD","LU2210150020.SGD","SG9999014021.USD","ELV.AU","BK4585","LU0314104364.USD","IE00BKPKM429.USD","LU2210149790.SGD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK7095","SG9999014013.SGD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2608207938","title":"Assessing Elevance Health (ELV) Valuation After Recent Share Price Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=2608207938","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608207938?lang=en_us&edition=fundamental","pubTime":"2026-02-03 17:24","pubTimestamp":1770110667,"startTime":"0","endTime":"0","summary":"Elevance Health (ELV) has drawn investor attention after recent share price moves, with the stock down 9.3% over the past week and 3.5% over the month, despite longer term gains.\nSee our latest analysis for Elevance Health.\nThat recent 9.3% 7 day share price decline and 3.5% 30 day share price decline come after a 7.96% 90 day share price return. At the same time, the 1 year total shareholder return of 13.99% and 3 year total shareholder return of 25.28% indicate that momentum has been fading...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/assessing-elevance-health-elv-valuation-after-recent-share-p","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/assessing-elevance-health-elv-valuation-after-recent-share-p","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0345770993.USD","BK4588","LU0251131958.USD","ELV","LU0433182093.SGD","LU1489326972.SGD","LU2237957811.SGD","LU0006306889.USD","LU0106261372.USD","LU0477156953.USD","LU0061474960.USD","LU0320765489.SGD","LU0058720904.USD","BK4154","ELV.AU","LU0068578508.USD","SG9999004303.SGD","LU0170899867.USD","LU0251142724.SGD","LU0557290698.USD","LU0314104364.USD","LU2430703251.USD","LU1670628061.USD","LU2430703095.HKD","LU1201861249.SGD","LU0130517989.USD","SGXZ23171101.USD","LU0114720955.EUR","LU1983299246.USD","LU0187121727.USD","LU2237957902.USD","LU2357305700.SGD","LU2362541273.HKD","LU0957791311.USD","LU0208291251.USD","LU0289739699.SGD","LU1815333072.USD","LU2505996681.GBP","LU2505996509.AUD","LU1023059063.AUD","LU2592432038.USD","LU0070302665.USD","LU0225283273.USD","LU2430703178.SGD","LU0648001328.SGD","LU0234570918.USD","LU0742534661.SGD","LU1720051108.HKD","LU2362541513.USD","LU0048573561.USD"],"gpt_icon":0},{"id":"2607024712","title":"Stardust Power Appoints Bruce Czachor as General Counsel","url":"https://stock-news.laohu8.com/highlight/detail?id=2607024712","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607024712?lang=en_us&edition=fundamental","pubTime":"2026-01-31 06:02","pubTimestamp":1769810542,"startTime":"0","endTime":"0","summary":"Stardust Power Inc. has appointed Bruce Czachor as General Counsel. He will oversee legal, regulatory, and corporate governance matters and report directly to CEO Roshan Pujari. Czachor brings over 30 years of experience in the energy and mining sectors, including previous roles at Piedmont Lithium Inc. and Paringa Resources Limited.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stardust Power Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 30, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nNDL9RQ8sX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7104","BK7095","BK4096","ELV.AU","TM1.AU","SDST"],"gpt_icon":0},{"id":"2607066091","title":"Is Elevra Lithium (ASX:ELV) Fairly Priced After Recent Share Price Pullback?","url":"https://stock-news.laohu8.com/highlight/detail?id=2607066091","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607066091?lang=en_us&edition=fundamental","pubTime":"2026-01-30 04:30","pubTimestamp":1769718616,"startTime":"0","endTime":"0","summary":"If you are wondering whether Elevra Lithium's current share price reflects its true worth, this article walks you through what the numbers are actually saying about value.\nThe stock last closed at A$7.47, with a 22.6% decline over the past 7 days and an 8.6% decline over 30 days, set against a 116.5% return over 1 year and a 5.7% decline year to date.\nRecent coverage around Elevra Lithium has focused on its position within the lithium sector and how sentiment around future demand has been...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-elv/elevra-lithium-shares/news/is-elevra-lithium-asxelv-fairly-priced-after-recent-share-pr","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-elv/elevra-lithium-shares/news/is-elevra-lithium-asxelv-fairly-priced-after-recent-share-pr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1280957306.USD","LU0187121727.USD","LU0314106906.USD","LU0068578508.USD","ELV","LU2505996509.AUD","ELV.AU","SG9999004303.SGD","SG9999011175.SGD","LU0006306889.USD","LU0557290698.USD","LU0477156953.USD","LU2237957811.SGD","LU1670627923.USD","LU2362541513.USD","LU0985489474.SGD","LU0106261372.USD","LU0225283273.USD","LU0234570918.USD","LU2362541273.HKD","LU0345770308.USD","LU0345770993.USD","BK4585","DCF","LU2108987350.USD","LU0980610538.SGD","LU0208291251.USD","LU0433182093.SGD","LU0648001328.SGD","LU0742534661.SGD","LU0061474960.USD","BK4588","LU0048573561.USD","LU1201861249.SGD","LU2244417387.USD","LU2362540622.SGD","LU2505996681.GBP","LU0170899867.USD","LU0251142724.SGD","LU0314104364.USD","LU0130517989.USD","LU0878866978.SGD","LU0882574055.USD","LU0957791311.USD","LU0122379950.USD","LU0130102774.USD","LU0251131958.USD","LU0114720955.EUR","LU2430703095.HKD","SG9999001077.SGD"],"gpt_icon":0},{"id":"2607674233","title":"Is Elevance Health (ELV) Using Rising Revenue and a Higher Dividend to Redefine Its Capital Strategy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2607674233","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607674233?lang=en_us&edition=fundamental","pubTime":"2026-01-28 23:26","pubTimestamp":1769614004,"startTime":"0","endTime":"0","summary":"Elevance Health has reported past fourth-quarter and full-year 2025 results, with revenue rising to US$49.75 billion for the quarter and US$199.13 billion for the year, while annual net income and earnings per share were slightly lower than in 2024.\nAlongside earnings, the company increased its first-quarter 2026 dividend to US$1.72 per share and continued long-running share repurchases, highlighting an ongoing emphasis on returning capital to shareholders.\nWe’ll now examine how Elevance...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/is-elevance-health-elv-using-rising-revenue-and-a-higher-div","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/is-elevance-health-elv-using-rising-revenue-and-a-higher-div","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ELV.AU","ELV"],"gpt_icon":0},{"id":"2606790488","title":"GUIDANCE: (ELV) Elevance Health Expects 2026 Adjusted EPS At Least $25.50","url":"https://stock-news.laohu8.com/highlight/detail?id=2606790488","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606790488?lang=en_us&edition=fundamental","pubTime":"2026-01-28 19:05","pubTimestamp":1769598307,"startTime":"0","endTime":"0","summary":"GUIDANCE: (ELV) Elevance Health Expects 2026 Adjusted EPS At Least $25.50","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"41dce0e9d5c246067d8bbccf3edce0e4","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ELV.AU","ELV"],"gpt_icon":0},{"id":"2606566752","title":"Elevra Lithium Posts Lower Fiscal Q2 Spodumene Concentrate Production at Canada Project; Shares Fall 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606566752","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606566752?lang=en_us&edition=fundamental","pubTime":"2026-01-28 08:50","pubTimestamp":1769561453,"startTime":"0","endTime":"0","summary":"Elevra Lithium  produced 44,154 dry metric tonnes  and sold 66,016 dmt of spodumene concentrate during the fiscal second quarter ended Dec. 31, 2025, from its North American Lithium operations in Canada, according to a Wednesday filing with the Australian bourse.The concentrate was sold at an average realized price of $998 per dmt to earn revenue of $66 million during the quarter, the filing said.In the December 2024 quarter, the company produced 50,922 dmt and sold 66,035 dmt of concentrate concentrate.For fiscal 2026, the company lowered its spodumene concentrate production guidance to a range of 180,000 dmt to 190,000 dmt from its previous guidance of 195,000 dmt to 210,000 dmt, the filing added.It also lowered its fiscal 2026 spodumene concentrate sales guidance to a range of 170,000 dmt to 190,000 dmt from its prior forecast of 195,000 dmt to 210,000 dmt.The company raised its unit operating cost guidance for the fiscal year to $860 to $880 per dmt, up from its previous guidance o","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ELV.AU","BK7095"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":66,"code":"91000000","status":"200"}]}}